SAMD8
Sphingomyelin synthase-related protein 1
Also known as: FLJ25082, SAMD8_HUMAN, SMSr
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96LT4
- Gene
- SAMD8
- Ensembl
- ENSG00000156671
- Chromosome
- 10
- Canonical length
- 415 aa
- Protein class
- Predicted membrane proteins
- Subcellular location
- Endoplasmic reticulum,Cytosol
OverviewNCBI Gene
Predicted to enable ceramide cholinephosphotransferase activity and sphingomyelin synthase activity. Involved in ceramide biosynthetic process and regulation of ceramide biosynthetic process. Located in cytosol and endoplasmic reticulum membrane. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
415 residues, UniProt reviewed canonical sequence.
>Q96LT4|SAMD8
1 MAGPNQLCIR RWTTKHVAVW LKDEGFFEYV DILCNKHRLD GITLLTLTEY DLRSPPLEIK
61 VLGDIKRLML SVRKLQKIHI DVLEEMGYNS DSPMGSMTPF ISALQSTDWL CNGELSHDCD
121 GPITDLNSDQ YQYMNGKNKH SVRRLDPEYW KTILSCIYVF IVFGFTSFIM VIVHERVPDM
181 QTYPPLPDIF LDSVPRIPWA FAMTEVCGMI LCYIWLLVLL LHKHRSILLR RLCSLMGTVF
241 LLRCFTMFVT SLSVPGQHLQ CTGKIYGSVW EKLHRAFAIW SGFGMTLTGV HTCGDYMFSG
301 HTVVLTMLNF FVTEYTPRSW NFLHTLSWVL NLFGIFFILA AHEHYSIDVF IAFYITTRLF
361 LYYHTLANTR AYQQSRRARI WFPMFSFFEC NVNGTVPNEY CWPFSKPAIM KRLIGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SAMD8 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 6
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 33 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 33 nTPM
- skeletal muscle: 25 nTPM
- cerebral cortex: 24 nTPM
- retina: 21 nTPM
- midbrain: 20 nTPM
- bone marrow: 16 nTPM
Single-cell type
- neutrophils: 401 nCPM
- esophageal apical cells: 245 nCPM
- neutrophil progenitors: 198 nCPM
- syncytiotrophoblasts: 176 nCPM
- myonuclei: 169 nCPM
- esophageal suprabasal cells: 149 nCPM
Immune cell
- neutrophil: 19 nTPM
- non-classical monocyte: 6.6 nTPM
- naive B-cell: 5.9 nTPM
- memory B-cell: 5.5 nTPM
- intermediate monocyte: 4.8 nTPM
- NK-cell: 4 nTPM
Brain region
- white matter: 67 nTPM
- midbrain: 58 nTPM
- spinal cord: 57 nTPM
- medulla oblongata: 55 nTPM
- basal ganglia: 52 nTPM
- cerebellum: 50 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SAMD8.
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 30 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.73
- gnomAD pLI
- 0
- gnomAD missense Z
- 2.89
- DepMap mean gene effect
- 0
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- ceramide biosynthetic process
- regulation of ceramide biosynthetic process
- sphingomyelin biosynthetic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SAMD8 as an antibody target. Whether an autoantibody or antibody against SAMD8 could matter depends on whether native SAMD8 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SAMD8 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SAMD8 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...